ES255386A1 - Procedure for preparing derivatives of 3,4-dihydro-1,2,4-benzotiadiazina-1,1, -idºxido (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for preparing derivatives of 3,4-dihydro-1,2,4-benzotiadiazina-1,1, -idºxido (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES255386A1
ES255386A1 ES0255386A ES255386A ES255386A1 ES 255386 A1 ES255386 A1 ES 255386A1 ES 0255386 A ES0255386 A ES 0255386A ES 255386 A ES255386 A ES 255386A ES 255386 A1 ES255386 A1 ES 255386A1
Authority
ES
Spain
Prior art keywords
formula
dihydro
translation
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0255386A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Publication of ES255386A1 publication Critical patent/ES255386A1/en
Expired legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Process for preparing 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide derivatives of the formula ** (See formula) ** where n means 4 or 5, and of salts thereof, characterized in that in 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxides of the formula ** (See formula) ** where n has the above-mentioned meaning, the bivalence C = N is reduced or a 2,4-disulfamyl-aniline of the formula is transformed ** (See formula) ** with an aldehyde of the formula (see formula), or a nitrobenzole of the formula is transformed ** (See formula) ** with an aldehyde of the formula (CH2) n-CH-CH2-CHO, where n has the above-mentioned meaning and is reduced and if desired, salts obtained in the free compounds, or the free compounds obtained in their you go out. (Machine-translation by Google Translate, not legally binding)
ES0255386A 1959-02-04 1960-01-29 Procedure for preparing derivatives of 3,4-dihydro-1,2,4-benzotiadiazina-1,1, -idºxido (Machine-translation by Google Translate, not legally binding) Expired ES255386A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79104459A 1959-02-04 1959-02-04

Publications (1)

Publication Number Publication Date
ES255386A1 true ES255386A1 (en) 1960-09-16

Family

ID=25152502

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0255386A Expired ES255386A1 (en) 1959-02-04 1960-01-29 Procedure for preparing derivatives of 3,4-dihydro-1,2,4-benzotiadiazina-1,1, -idºxido (Machine-translation by Google Translate, not legally binding)

Country Status (4)

Country Link
BE (1) BE587225A (en)
DK (2) DK118137B (en)
ES (1) ES255386A1 (en)
OA (1) OA01196A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20074134B (en) 2002-08-19 2007-06-25 Pfizer Prod Inc Combination therapy for hyperproliferative diseases
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (en) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPANE-1- AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLERosis AND CARDIOVASCULAR DISEASES
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
DK115554B (en) 1969-10-20
DK118137B (en) 1970-07-13
BE587225A (en) 1960-08-02
OA01196A (en) 1969-01-25

Similar Documents

Publication Publication Date Title
ES254767A1 (en) Derivatives of 2-h-1, 2, 4-benzo thiadiazine-1, 1-dioxide
ES255386A1 (en) Procedure for preparing derivatives of 3,4-dihydro-1,2,4-benzotiadiazina-1,1, -idºxido (Machine-translation by Google Translate, not legally binding)
ES237332A1 (en) Method of killing nematodes by treatment with 3-halo-2, 3-dihydrothiophene-1, 1-dioxide
ES325472A1 (en) Procedure for the obtaining of de-amino-phe-arg-vasopresina. (Machine-translation by Google Translate, not legally binding)
ES299388A1 (en) Procedure for the production of a new polipepture and its derivatives (Machine-translation by Google Translate, not legally binding)
ES303554A1 (en) Procedure for the obtaining of polipepturos. (Machine-translation by Google Translate, not legally binding)
ES327846A1 (en) Procedure for the preparation of derivatives of isoindolobenzodiacepin-6-ona. (Machine-translation by Google Translate, not legally binding)
ES287702A1 (en) Procedure for the preparation of new heterocyclic compounds (Machine-translation by Google Translate, not legally binding)
ES255856A1 (en) Procedure for obtaining a derivative of 1,1-dioxide from 3,4-hydride-1,2,4-benzotiadiacin (Machine-translation by Google Translate, not legally binding)
ES405859A1 (en) Digitoxsyl acrylonitrile derivatives
DK117072B (en) Process for the preparation of 3-substituted-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide derivatives or acid or base salts thereof.
ES255227A1 (en) Procedure for obtaining a derivative of 1,1-dioxide from 3,4-dihydro-1,2,4-benzotiadiacin (Machine-translation by Google Translate, not legally binding)
ES328752A1 (en) Procedure for the production of benzodiacepin-8-ona derivatives. (Machine-translation by Google Translate, not legally binding)
ES277579A1 (en) Procedure for the manufacture of 3-oxo-3, 4-dihydro-1, 2, 4-bezotiadiazina1, 1-dioxides replaced in the second position (Machine-translation by Google Translate, not legally binding)
ES240352A1 (en) Procedure for the obtaining of new substitute basic heterocils (Machine-translation by Google Translate, not legally binding)
ES249220A1 (en) Procedure for obtaining 6-chlorine-7-sulfamil-3-4-dihydro-1,2,4-benzotiadiazine-1,1-dioxide (Machine-translation by Google Translate, not legally binding)
ES294357A1 (en) Procedure for the obtaining of new nonapeptures (Machine-translation by Google Translate, not legally binding)
DK126117B (en) Process for the preparation of 1,2,4-benzothiadiazine-1,1-dioxide compounds.
ES247571A1 (en) Procedure for the obtaining of new sulfonamins (Machine-translation by Google Translate, not legally binding)
ES241154A1 (en) Procedure for obtaining a new piradicine compound (Machine-translation by Google Translate, not legally binding)
ES277151A1 (en) Procedure for the preparation of 2,5-di- [benzoxazolil- (2)] - thiophene (Machine-translation by Google Translate, not legally binding)
ES296682A1 (en) Procedure for the obtaining of a new isoquinoline and its derivatives (Machine-translation by Google Translate, not legally binding)
ES247607A1 (en) Procedure for the obtaining of a new heterociclic compound (Machine-translation by Google Translate, not legally binding)
ES57255U (en) Perfected plug (Machine-translation by Google Translate, not legally binding)
ES279905A1 (en) Procedure for preparation of general formula compounds (Machine-translation by Google Translate, not legally binding)